Organoid technology demonstrates effects of potential drugs for COVID-19 on the lung regeneration

Cell Prolif. 2020 Dec;53(12):e12928. doi: 10.1111/cpr.12928. Epub 2020 Oct 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • COVID-19 / pathology*
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Cell Culture Techniques
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism
  • Lopinavir / pharmacology
  • Lopinavir / therapeutic use
  • Lung / physiology*
  • Mice
  • Organoids / drug effects
  • Regeneration / drug effects*
  • SARS-CoV-2 / isolation & purification

Substances

  • Antiviral Agents
  • Lopinavir